Eliscription Private Limited, a active private limited company, was established on 26 March 2013 in Hyderabad, Telangana, India. Engaging in medical transcription within the information and communication sector, it holds CIN: U74900TG2013PTC086622. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Employing 1 professional, Its leadership includes Sri Kanth Kasala (Ceo), Vanitha Datla (Director), Ramesh Datla (Director). It holds ₹6.43 Cr open charges and ₹5.31 Cr settled loans. Its latest AGM occurred on 28 September 2024, with the balance sheet filed on 31 March 2024. It is based at B-91, Apie,Sanathnagar, Industrialestate Extension, Hyderabad, Telangana, 500018.
U74900TG2013PTC086622
086622
26 March 2013
₹5.00 M
₹0.10 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Eliscription Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sri Kanth Kasala | Ceo | 01 Jan 2021 | Current |
| Vanitha Datla | Director | 26 Mar 2013 | Current |
| Ramesh Datla | Director | 26 Mar 2013 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Eliscription Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 2.44% increase. The company also saw a slight decrease in profitability, with a 9.18% decrease in profit. The company's net worth observed a substantial decline by a decrease of 81.11%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Eliscription had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹64,300,000.00
₹53,092,647.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Mar 2022 | Others | ₹1.43 Cr | Open |
| 31 Mar 2021 | Others | ₹2.50 Cr | Open |
| 24 Jun 2020 | Others | ₹2.50 Cr | Open |
| 30 Sep 2021 | Axis Bank Limited | ₹5.59 M | Satisfied |
| 15 Feb 2019 | Axis Bank Limited | ₹6.40 M | Satisfied |
Explore comprehensive loan charge details -
Eliscription has a workforce of 1 employees as of Apr 01, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Eliscription, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eliscription's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Eliscription Private Limited last Annual general meeting of members was held on 28 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity A charge registered on 01 Sep 2018 via Charge ID 100200086 with Others was fully satisfied on 04 Sep 2024. was completed.
Eliscription Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was recorded as a recent event.
A charge registered on 30 Sep 2021 via Charge ID 100505725 with Axis Bank Limited was fully satisfied on 04 Apr 2023. was recorded as a recent event.
A charge with Others of Rs. 14.30 M registered on 31 Mar 2022 with Charge ID 100561560 was modified on 21 Mar 2023. was recorded as a recent event.
A charge with Others of Rs. 25.00 M registered on 31 Mar 2021 with Charge ID 100435301 was modified on 21 Mar 2023. was recorded as a recent event.
The CIN of Eliscription Private Limited is U74900TG2013PTC086622.
Eliscription Private Limited is headquartered at B-91, Apie,Sanathnagar, Industrialestate Extension, Hyderabad, Telangana, 500018.
Eliscription Private Limited was incorporated on 26 March 2013.
The current directors of Eliscription Private Limited are
The primary industry of Eliscription Private Limited is Information And Communication.
Eliscription Private Limited is unlisted.
The authorized capital of Eliscription Private Limited is ₹5.00 M, and the paid-up capital is ₹0.10 M.
The compliance status of Eliscription Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX